349 related articles for article (PubMed ID: 23867625)
61. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
Zhu H
Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
[TBL] [Abstract][Full Text] [Related]
62. The "O" class: crafting clinical care with FoxO transcription factors.
Maiese K; Chong ZZ; Hou J; Shang YC
Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
[TBL] [Abstract][Full Text] [Related]
63. Wnt signaling regulates hepatic metabolism.
Liu H; Fergusson MM; Wu JJ; Rovira II; Liu J; Gavrilova O; Lu T; Bao J; Han D; Sack MN; Finkel T
Sci Signal; 2011 Feb; 4(158):ra6. PubMed ID: 21285411
[TBL] [Abstract][Full Text] [Related]
64. Liver-specific expression of dominant-negative transcription factor 7-like 2 causes progressive impairment in glucose homeostasis.
Ip W; Shao W; Song Z; Chen Z; Wheeler MB; Jin T
Diabetes; 2015 Jun; 64(6):1923-32. PubMed ID: 25576056
[TBL] [Abstract][Full Text] [Related]
65. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways.
Liu Y; Liu Y; Zhang R; Wang X; Huang F; Yan Z; Nie M; Huang J; Wang Y; Wang Y; Chen L; Yin L; He B; Deng Z
Int J Biochem Cell Biol; 2014 Feb; 47():47-56. PubMed ID: 24300824
[TBL] [Abstract][Full Text] [Related]
66. Inducible Activation of FGFR2 in Adult Mice Promotes Bone Formation After Bone Marrow Ablation.
Xu W; Luo F; Wang Q; Tan Q; Huang J; Zhou S; Wang Z; Sun X; Kuang L; Jin M; Su N; Jiang W; Chen L; Qi H; Zhu Y; Chen B; Chen H; Chen S; Gao Y; Xu X; Deng C; Chen L; Xie Y; Du X
J Bone Miner Res; 2017 Nov; 32(11):2194-2206. PubMed ID: 28650109
[TBL] [Abstract][Full Text] [Related]
67. SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.
Chew LJ; Shen W; Ming X; Senatorov VV; Chen HL; Cheng Y; Hong E; Knoblach S; Gallo V
J Neurosci; 2011 Sep; 31(39):13921-35. PubMed ID: 21957254
[TBL] [Abstract][Full Text] [Related]
68. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T; George Fantus I; Sun J
Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
[TBL] [Abstract][Full Text] [Related]
69. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
[TBL] [Abstract][Full Text] [Related]
70. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
71. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton.
Almeida M; Ambrogini E; Han L; Manolagas SC; Jilka RL
J Biol Chem; 2009 Oct; 284(40):27438-48. PubMed ID: 19657144
[TBL] [Abstract][Full Text] [Related]
72. Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs.
Chen D; Gong Y; Xu L; Zhou M; Li J; Song J
Cell Prolif; 2019 Mar; 52(2):e12540. PubMed ID: 30397974
[TBL] [Abstract][Full Text] [Related]
73. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.
Saidak Z; Haÿ E; Marty C; Barbara A; Marie PJ
Aging Cell; 2012 Jun; 11(3):467-74. PubMed ID: 22321691
[TBL] [Abstract][Full Text] [Related]
74. Amyloid β peptide promotes bone formation by regulating Wnt/β-catenin signaling and the OPG/RANKL/RANK system.
Yang B; Li S; Chen Z; Feng F; He L; Liu B; He T; Wang X; Chen R; Chen Z; Xie P; Rong L
FASEB J; 2020 Mar; 34(3):3583-3593. PubMed ID: 31944393
[TBL] [Abstract][Full Text] [Related]
75. Redirecting TGF-
Qiao X; Rao P; Zhang Y; Liu L; Pang M; Wang H; Hu M; Tian X; Zhang J; Zhao Y; Wang XM; Wang C; Yu H; Guo F; Cao Q; Wang Y; Wang YM; Zhang GY; Lee VW; Alexander SI; Zheng G; Harris DCH
J Am Soc Nephrol; 2018 Feb; 29(2):557-570. PubMed ID: 29180394
[TBL] [Abstract][Full Text] [Related]
76. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
[TBL] [Abstract][Full Text] [Related]
77. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
Hori YS; Kuno A; Hosoda R; Horio Y
PLoS One; 2013; 8(9):e73875. PubMed ID: 24040102
[TBL] [Abstract][Full Text] [Related]
78. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.
Gaur T; Lengner CJ; Hovhannisyan H; Bhat RA; Bodine PV; Komm BS; Javed A; van Wijnen AJ; Stein JL; Stein GS; Lian JB
J Biol Chem; 2005 Sep; 280(39):33132-40. PubMed ID: 16043491
[TBL] [Abstract][Full Text] [Related]
79. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.
Beier EE; Sheu TJ; Dang D; Holz JD; Ubayawardena R; Babij P; Puzas JE
J Biol Chem; 2015 Jul; 290(29):18216-18226. PubMed ID: 25975268
[TBL] [Abstract][Full Text] [Related]
80. Scara3 regulates bone marrow mesenchymal stem cell fate switch between osteoblasts and adipocytes by promoting Foxo1.
Chen P; Hu B; Xie LQ; Jiang TJ; Xia ZY; Peng H
Cell Prolif; 2021 Aug; 54(8):e13095. PubMed ID: 34254370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
